Our expertise
Eurofins CDMO (Contract Development & Manufacturing Organization) provides active pharmaceutical ingredient (API) and drug substance development services for complex, niche, small molecule programs from preclinical to Phase III and commercial manufacturing.
Our integrated group of companies provides a seamless transition for API and drug substances from the initial discovery stages of the program to commercialization and on-the-shelf. Expertise and support at each phase of the drug program is available from development to cGMP manufacturing.
To learn more